The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review
Familial Cancer · 2024
DOI: 10.1007/s10689-024-00390-3 ↗Kurz gefasst
Fallbericht in der Zeitschrift Familial Cancer, 2024. Verfasst von Hiroyuki Matsubayashi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetic Medicine Promotion, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi, Suntogun, Shizuoka, 411-8777, Japan. h.matsubayashi@s…. Hauptthemen laut MEDLINE: Piperazines, Pancreatic Neoplasms, Phthalazines, Carcinoma, Acinar Cell. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
A 73-year-old Japanese man with a history of distal biliary cancer treated by pancreatoduodenectomy developed pancreatic acinar cell carcinoma (PACC) treated by remnant pancreatectomy and adjuvant chemotherapy. Thirteen months after surgery, multiple liver metastases developed and FOLFOX chemotherapy was initiated. Based on the PACC diagnosis and a positive family history for breast and ovarian cancer genetic testing was performed which revealed a pathogenic germline BRCA2 variant (c.8629G > T, p.Glu2877Ter). Olaparib therapy was initiated and the metastases responded well (partial response). PACC is a BRCA2-associated cancer which may respond well to PARP inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Genetic Medicine Promotion, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi, Suntogun, Shizuoka, 411-8777, Japan. h.matsubayashi@scchr.jp.
- Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan. h.matsubayashi@scchr.jp.
- Division of Medical Oncology and Hematology, Faculty of Medicine, Oita University, Oita, Japan.
- Division of GI Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
- Division of Genetic Medicine Promotion, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi, Suntogun, Shizuoka, 411-8777, Japan.
- Division of Pathology, Shizuoka Cancer Center, Shizuoka, Japan.
Förderung
- JSPS KAKENHI
Zitieren
APA
Matsubayashi, H., Todaka, A., Tsushima, T., Kiyozumi, Y., Harada, R., Ishihara, E., Higashigawa, S., Ohike, N., Sakamoto, H., Sato, J., Ishiwatari, H., Sugiura, T., & Uesaka, K. (2024). The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review. Familial Cancer. https://doi.org/10.1007/s10689-024-00390-3
Vancouver
Matsubayashi H, Todaka A, Tsushima T, Kiyozumi Y, Harada R, Ishihara E, et al. The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review. Familial Cancer. 2024. doi:10.1007/s10689-024-00390-3
BibTeX
@article{Matsubayashi2024,
author = {Matsubayashi, Hiroyuki and Todaka, Akiko and Tsushima, Takahiro and Kiyozumi, Yoshimi and Harada, Rina and Ishihara, Eiko and Higashigawa, Satomi and Ohike, Nobuyuki and Sakamoto, Hiroki and Sato, Junya and Ishiwatari, Hirotoshi and Sugiura, Teichi and Uesaka, Katsuhiko},
title = {The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review},
journal = {Familial Cancer},
year = {2024},
doi = {10.1007/s10689-024-00390-3}
}
EUVIMED